Chen H, Smit-McBride Z, Lewis S, Sharif M, Privalsky M L
Department of Microbiology, University of California, Davis 95616.
Mol Cell Biol. 1993 Apr;13(4):2366-76. doi: 10.1128/mcb.13.4.2366-2376.1993.
The erb A oncogene is a dominant negative allele of a thyroid hormone receptor gene and acts in the cancer cell by encoding a transcriptional repressor. We demonstrate here that the DNA sequence recognition properties of the oncogenic form of the erb A protein are significantly altered from those of the normal thyroid hormone receptors and more closely resemble those of the retinoic acid receptors; this alteration appears to play an important role in defining the targets of erb A action in neoplasia. Unexpectedly, the novel DNA recognition properties of erb A are encoded by an N-terminal region not previously implicated as playing this function in current models of receptor-DNA interaction. Two N-terminal erb A amino acids in particular, histidine 12 and cysteine 32, contribute to this phenomenon, acting in conjunction with amino acids in the zinc finger domain. The effects of the N-terminal domain can be observed at the level of both DNA binding and transcriptional modulation. Our results indicate that unanticipated determinants within the nuclear hormone receptors participate in DNA sequence recognition and may contribute to the differential target gene specificity displayed by different receptor forms.
erb A癌基因是甲状腺激素受体基因的显性负等位基因,通过编码转录抑制因子在癌细胞中发挥作用。我们在此证明,erb A蛋白致癌形式的DNA序列识别特性与正常甲状腺激素受体的特性有显著改变,且更类似于维甲酸受体的特性;这种改变似乎在确定erb A在肿瘤形成中的作用靶点方面起着重要作用。出乎意料的是,erb A新的DNA识别特性由一个N端区域编码,在当前受体与DNA相互作用模型中,该区域以前未被认为发挥此功能。特别是erb A的两个N端氨基酸,组氨酸12和半胱氨酸32,与锌指结构域中的氨基酸共同作用,促成了这一现象。N端结构域的作用在DNA结合和转录调节水平均可观察到。我们的结果表明,核激素受体内存在未预料到的决定因素参与DNA序列识别,可能导致不同受体形式表现出不同的靶基因特异性。